Business Description
Biogena Group Invest AG
ISIN : ATBIOGENA005
Share Class Description:
WBO:BIO: Ordinary SharesTotal Employee Number:
3Compare
Compare
Traded in other countries / regions
BIO.Austria IPO Date
2020-11-27Description
Biogena Group Invest AG is a holding company whose purpose is the acquisition, holding, and management of investments. The company is engaged in the development and distribution of products and services in the field of health and nutrition. Its products include Vitamins, Minerals, Trace elements, Amino acids, Gut bacteria, Fibre, Enzymes, Omega 3 fatty acids, Collagen, Hyaluronic acid, Algae, Functional Mushrooms, Antioxidants, Greens, and MSM. Its brands include AESTHETICS, SPORTS, ONE, and PETS.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.99 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 179.07 | |||||
Beneish M-Score | -2.13 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.8 | |||||
3-Year EBITDA Growth Rate | -0.9 | |||||
3-Year EPS without NRI Growth Rate | -0.4 | |||||
3-Year Book Growth Rate | 1.1 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 88.14 | |||||
9-Day RSI | 79.86 | |||||
14-Day RSI | 75.41 | |||||
3-1 Month Momentum % | 43.71 | |||||
6-1 Month Momentum % | 43.71 | |||||
12-1 Month Momentum % | 73.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 26.31 | |||||
Quick Ratio | 26.31 | |||||
Cash Ratio | 0.47 | |||||
Days Sales Outstanding | 4.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.93 | |||||
Dividend Payout Ratio | 0.68 | |||||
3-Year Dividend Growth Rate | -20.6 | |||||
Forward Dividend Yield % | 0.93 | |||||
5-Year Yield-on-Cost % | 1.06 | |||||
Shareholder Yield % | 1.06 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | 51 | |||||
Net Margin % | 83.48 | |||||
EBITDA Margin % | 84.62 | |||||
FCF Margin % | -2.56 | |||||
OCF Margin % | -2.56 | |||||
ROE % | 3.35 | |||||
ROA % | 3.29 | |||||
ROIC % | 2.02 | |||||
3-Year ROIIC % | 39.82 | |||||
ROCE % | 3.39 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 74.99 | |||||
PE Ratio without NRI | 74.99 | |||||
PS Ratio | 63.07 | |||||
PB Ratio | 2.51 | |||||
Price-to-Tangible-Book | 2.51 | |||||
EV-to-EBIT | 74.48 | |||||
EV-to-EBITDA | 74.48 | |||||
EV-to-Revenue | 63.02 | |||||
EV-to-FCF | -2081 | |||||
Price-to-GF-Value | 1.59 | |||||
Price-to-Graham-Number | 2.89 | |||||
| Price-to-Net-Current-Asset-Value | 17.34 | |||||
Earnings Yield (Greenblatt) % | 1.35 | |||||
FCF Yield % | -0.04 | |||||
Forward Rate of Return (Yacktman) % | -13.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biogena Group Invest AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.351 | ||
| EPS (TTM) (€) | 0.074 | ||
| Beta | 0.8644 | ||
| 3-Year Sharpe Ratio | 0.49 | ||
| 3-Year Sortino Ratio | 1.07 | ||
| Volatility % | 33.95 | ||
| 14-Day RSI | 75.41 | ||
| 14-Day ATR (€) | 0.292815 | ||
| 20-Day SMA (€) | 4.509 | ||
| 12-1 Month Momentum % | 73.6 | ||
| 52-Week Range (€) | 2.5 - 5.7 | ||
| Shares Outstanding (Mil) | 3.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biogena Group Invest AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biogena Group Invest AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.050000 Cash Dividend | 2026-04-15 | 3.06 (-0.65%) | ||
| EUR 0.050000 Cash Dividend | 2025-04-16 | 1.83 (+0.00%) |
Show
Entries
Biogena Group Invest AG Frequently Asked Questions
What is Biogena Group Invest AG(WBO:BIO)'s stock price today?
The current price of WBO:BIO is €5.55. The 52 week high of WBO:BIO is €5.70 and 52 week low is €2.50.
When is next earnings date of Biogena Group Invest AG(WBO:BIO)?
The next earnings date of Biogena Group Invest AG(WBO:BIO) is .
Does Biogena Group Invest AG(WBO:BIO) pay dividends? If so, how much?
The Dividend Yield %  of Biogena Group Invest AG(WBO:BIO) is 0.93% (As of Today), Highest Dividend Payout Ratio of Biogena Group Invest AG(WBO:BIO) was 1.33. The lowest was 0.22. And the median was 0.68. The  Forward Dividend Yield % of Biogena Group Invest AG(WBO:BIO) is 0.93%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Biogena Group Invest AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers